Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06288737 · ClinicalTrials.gov registry record
Assessing Patient Engagement in Keratoconus Clinical Research
A clinical trial, sponsored by Power Life Sciences.
- Not yet
- Registry status
- 500
- Enrollment target
NCT06288737: Clinical Trial study, sponsored by Power Life Sciences.
NCT06288737 is a clinical trial that has not yet begun recruiting, run by Power Life Sciences. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06288737 has not yet begun recruiting, sponsored by Power Life Sciences.
- NOT YET RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in keratoconus clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors. In essence, this trial aims to deepen understanding of the factors influencing participation in keratoconus clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-03 |
| Est. Completion | 2027-03 |
What is known before NCT06288737 opens enrollment
NCT06288737 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06288737 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06288737 about?
NCT06288737 is a clinical study titled "Assessing Patient Engagement in Keratoconus Clinical Research". This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in keratoconus clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors. In essence, this trial aims to deep...
What is the current status of trial NCT06288737?
This trial is currently not yet recruiting. The enrollment target is 500 participants. The study started on 2025-03. Estimated completion is 2027-03.
Who is sponsoring clinical trial NCT06288737?
This trial is sponsored by Power Life Sciences, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia